Access cutting-edge decompensated liver cirrhosis treatment through this clinical trial at a research site in Charleston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Charleston location
Preparing your pre-screening questions…
Access decompensated liver cirrhosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related decompensated liver cirrhosis treatment provided free
Check if you qualify for this decompensated liver cirrhosis clinical trial in Charleston, WV
No-Cost Study Care
Local to Charleston
Convenient for WV residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Decompensated cirrhosis (liver disease) occurs when liver function decreases to the extent that serious complications develop and can include internal bleeding, fluid buildup in the abdomen, or mental confusion. This reduced decreased liver function subsequently decreases life expectancy. There is a critical need for strategies to delay progression to decompensation and reduce the occurrence of serious complications. Currently, limited therapeutic options are available for managing decompensated liver disease, with beta-blockers (BB) being the only proven medication with significant benefits in preventing disease progression. Statins have been historically under- prescribed in cirrhosis due to concerns of liver damage. However, there is emerging evidence that statin use may be beneficial and able to lessen liver disease worsening, with studies demonstrating its safety. Thus, we aim to conduct a pilot randomized controlled trial (RCT) study of 50 subjects comparing the outcomes of decompensated cirrhotic patients receiving the statin, atorvastatin, and a non-selective beta-blocker (NSBB) versus those receiving NSBB plus placebo. Both groups will be followed for 12 months to investigate the feasibility, safety, and efficacy of combination therapy.
Sponsor: CAMC Health System
Yes, this clinical trial (NCT06764966) has an active research site in Charleston, WV that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for decompensated liver cirrhosis treatment options in Charleston, WV, this clinical trial (NCT06764966) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charleston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced decompensated liver cirrhosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all decompensated liver cirrhosis clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Charleston — not just this study.
Browse Pulmonary Embolism Trials in Charleston →